Cytomegalovirus (CMV)-encoded UL144 (truncated tumor necrosis factor receptor) and outcome of congenital CMV infection

Journal of Infectious Diseases

Volumn 194, Issue 4, 2006, Pages 464-473

  Arav Boger, Ravit ^a,b   Battaglia, Catherine A ^c   Lazzarotto, Tiziana ^d   Gabrielli, Liliana ^d   Zong, Jian C ^b   Hayward, Gary S ^b   Diener West, Marie ^c   Landini, Maria P ^d  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; TUMOR NECROSIS FACTOR RECEPTOR; VIRULENCE FACTOR;

ADULT; AMINO ACID SEQUENCE; AMNION FLUID; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; FEMALE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HUMAN; INTRAUTERINE INFECTION; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; NUCLEOTIDE SEQUENCE; OUTCOMES RESEARCH; PREGNANCY COMPLICATION; PREGNANCY TERMINATION; PRIORITY JOURNAL; UL144 A GENE; UL144 B GENE; UL144 C GENE; VIRUS GENE; VIRUS LOAD;

AMNIOTIC FLUID; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DISEASE TRANSMISSION, VERTICAL; FEMALE; FETUS; HUMANS; ITALY; MEMBRANE GLYCOPROTEINS; POLYMORPHISM, GENETIC; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, VIRUS; VIRAL PROTEINS;

EID: 33746739445     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/505427     Document Type: Article

References (27)

1. Stagno S. Cytomegalovirus. In: Remington JS, Klein JO, eds. Infectious diseases of the fetus and newborn infant. 4th ed. Philadelphia: WB Saunders, 1995:312-53,
2. Barbi M, Binda S, Primache V, Clerici D. Congenital cytomegalovirus infection in a northern Italian region. NEOCMV Group. Eur J Epidemiol 1998; 14:791-6.
3. Arav-Boger R, Pass RF. Diagnosis and management of cytomegalovirus infection in the newborn. Pediatr Ann 2002; 31:719-25.
4. Boppana SB, Fowler KB, Britt WJ, Stagno S, Pass RF. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics 1999; 104:55-60.
5. Stagno S, Pass RF, Cloud G, et al. Primary cytomegalovirus infection in pregnancy: incidence, transmission to fetus, and clinical outcome. JAMA 1986; 256:1904-8.
6. Fowler KB, Stagno S, Pass RF. Maternal age and congenital cytomegalovirus infection: screening of two diverse newborn populations, 1980-1990. J Infect Dis 1993; 168:552-6.
7. Guerra B, Lazzarotto T, Quarta S, et al. Prenatal diagnosis of symptomatic congenital cytomegalovirus infection. Am J Obstet Gynecol 2000; 183:476-82.
8. Demmler GJ, Infectious Diseases Society of America, Centers for Disease Control. Summary of a workshop on surveillance for congenital cytomegalovirus disease. Rev Infect Dis 1991; 13:315-29.
9. Fowler KB, Stagno S, Pass RF. Maternal immunity and prevention of congenital cytomegalovirus infection. JAMA 2003; 289:1008-11.
10. Lazzarotto T, Varani S, Guerra B, Nicolosi A, Lanari M, Landini MP. Prenatal indicators of congenital cytomegalovirus infection. J Pediatr 2000; 137:90-5.
11. Arav-Boger R, Willoughby RE, Pass RF, et al. Polymorphisms of the cytomegalovirus (CMV)-encoded tumor necrosis factor-α and β-chemokine receptors in congenital CMV disease. J Infect Dis 2002; 186: 1057-64.
12. Boppana SB, Fowler KB, Pass RF, et al. Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. J Pediatr 2005; 146:817-23.
13. Lanari M, Lazzarotto T, Venturi V, et al. Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns. Pediatrics 2006; 117:e76-83.
14. Bale JF Jr, Petheram SJ, Robertson M, Murph JR, Demmler G, Human cytomegalovirus a sequence and UL144 variability in strains from infected children, J Med Virol 2001; 65:90-6.
15. Meyer-Konig U, Vogelberg C, Bongarts A, et al. Glycoprotein B genotype correlates with cell tropism in vivo of human cytomegalovirus infection. J Med Virol 1998; 55:75-81.
16. Pignatelli S, Dal Monte P, Rossini G, Landini MP. Genetic polymorphisms among human cytomegalovirus (HCMV) wild-type strains. Rev Med Virol 2004; 14:383-410.
17. Cha TA, Tom E, Kemble GW, Duke GM, Mocarski ES, Spaete RR. Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol 1996; 70:78-83.
18. Benedict CA, Butrovich KD, Lurain NS, et al. Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. J Immunol 1999; 162:6967-70.
19. Picone O, Costa JM, Chaix ML, Ville Y, Rouzioux C, Leruez-Ville M. Human cytomegalovirus UL144 gene polymorphisms in congenital infections. J Clin Microbiol 2005; 43:25-9.
20. He R, Ruan Q, Xia C, et al. Sequence variability of human cytomegalovirus UL144 open reading frame in low-passage clinical isolates. Chin Med Sci J 2004; 19:293-7.
21. Murayama T, Takegoshi M, Tanuma J, Eizuru Y. Analysis of human cytomegalovirus UL144 variability in low-passage clinical isolates in Japan. Intervirology 2005; 48:201-6.
22. Lurain NS, Kapell KS, Huang DD, et al. Human cytomegalovirus UL144 open reading frame: sequence hypervariability in low-passage clinical isolates. J Virol 1999; 73:10040-50.
23. Gleaves CA, Smith TF, Shuster EA, Pearson GR. Rapid detection of cytomegalovirus in MRC-5 cells inoculated with urine specimens by using low-speed centrifugation and monoclonal antibody to an early antigen. J Clin Microbiol 1984; 19:917-9.
24. Lazzarotto T, Gabrielli L, Foschini MP, et al. Congenital cytomegalovirus infection in twin pregnancies: viral load in the amniotic fluid and pregnancy outcome. Pediatrics 2003; 112:e153-7.
25. Cheung TC, Humphreys IR, Potter KG, et al. Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway. Proc Natl Acad Sci USA 2005; 102:13218-23.
26. Marsters SA, Ayres TM, Skubatch M, Gray CL, Rothe M, Ashkenazi A. Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1. J Biol Chem 1997; 272:14029-32.
27. Granger SW, Rickert S. LIGHT-HVEM signaling and the regulation of T cell-mediated immunity. Cytokine Growth Factor Rev 2003; 14:289-96.